Tissue Heart Valves (THV)

SURGICAL
VALVE SOLUTIONS
EPIC™ PLUS MITRAL AND AORTIC STENTED TISSUE VALVES

The latest generation of the Epic™ Platform continues the Epic product family’s history of excellence. The future-forward design of the Epic Plus mitral and aortic valves gives you and your patients more choices when it comes to preserving long-term treatment paths.

SURGICAL VALVE SOLUTIONS
DURABILITY THAT WITHSTANDS THE LONG-TERM TEST OF TIME

10 YEARS

93.8%*
Freedom from SVD,
All patient ages (Epic™ Mitral Valve)¹

96.3%*
Freedom from SVD,
All patient ages (Epic™ Aortic Valve)²

SVD: structural valve deterioration.
*From stand-alone aortic or mitral valve replacements.

THE EPIC PLATFORM HAS DEMONSTRATED EXCELLENT DURABILITY IN YOUNGER PATIENTS

The Epic Mitral valve experience from Rennes shows excellent performance in younger patients, with a 10-year freedom from SVD of 87.7% for the age ≤ 59 subgroup.³

87.7%

EPIC MITRAL VALVE FREEDOM FROM SVD, AT 10 YEARS³

EPIC SUPRA VALVE DELIVERS EXCEPTIONAL DURABILITY AND PERFORMANCE

Optimal leaflet design minimizes regurgitation
Pericardial shield reduces abrasion by creating tissue-to-tissue interface
Epic™ valve 10-year durability data show outstanding aortic freedom from SVD²

96.3%

EPIC AORTIC VALVE FREEDOM FROM SVD, AT 10 YEARS²

STRONG IN VIVO HEMODYNAMICS

*NOTE: For references 2–5, data not from head-to-head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due to differences in trial protocols, endpoints, and/or patient populations. Data provided for informational purposes only.
**Pressure gradients approximated through Epic™ Aortic summary of safety and effectiveness data (SSED) matched with stent size equivalencies for the Epic™ Supra. Per Abbott Internal engineering specifications, a 19 mm Epic™ Supra has the same stent size as a 21 mm Epic™ Aortic and this relationship continues across all Epic™ Supra valve sizes.
^‡Indicates a third-party trademark, which is property of its respective owner.

BRINGING YOU...

Clinical Case clubs | Educational tools | Hot topics
Expert opinions | Live & online discussions

TV

Cleveland Clinic’s Porcine vs. Bovine Outcomes

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Epic™ HCP testimonial

Epic™ Mitral & Supra Aortic stented tissue valves HCP testimonial

Epic™ Mitral Valve

Epic™ Mitral stented tissue valve with Linx™ AC technology

Webinar 2022: Management of aortic and mitral valve disease

Webinar: Aortic & Mitral Valve Disease

Webinar 2022: Management of aortic and mitral valve disease

EACTS 2022: SMV repair vs replacement

EACTS 2022 Symposium: Surgical Mitral Valve Repair versus Replacement in the Modern Era of Transcatheter Valve Interventions.

References

Lehmann S, Jawad K, Meyer A, et al. Long-term follow-up after porcine xenograft mitral valve replacement. Presented at: 2017 American Association For Thoracic Surgery Mitral Conclave. April 27-28, 2017; New York, NY, USA.
Lehmann, S, Merk DR, Etz CD, et al. Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients. Eur J Cardiothorac Surg. 2016;49:1150-1156.
Anselmi A, Aymami M, Tomasi J et al. Durability of mitral valve replacement with a 3rd generation bioprosthesis. Ann Thorac Surg. 2021. doi: doi.org/10.1016/j.athoracsur.2021.03.097.
Biocor Instructions for Use.
Maitland A, Hirsch GA, and Pascoe EA. Hemodynamic performance of the St. Jude Medical Epic Supra Aortic Stented Valve. J Heart Valve Dis, 2011; 20:327-331.